| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 1 | +100.00% | +13.29% | -0.13% | +13.41% | +13.41% | — |
| 14d | 1 | +100.00% | +6.08% | -0.47% | +6.55% | +6.55% | — |
| 30d | 1 | +100.00% | +8.14% | +2.47% | +5.67% | +5.67% | — |
| 60d | 1 | +100.00% | +54.48% | +3.28% | +51.20% | +51.20% | — |
| 90d | 1 | +100.00% | +60.66% | +3.48% | +57.18% | +57.18% | — |
| 180d | 1 | +100.00% | +127.60% | +5.98% | +121.62% | +121.62% | — |
| 1y | 1(1 pending) | — | — | — | — | — | — |
| 2y | 1(1 pending) | — | — | — | — | — | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| ALXO ALX ONCOLOGY HOLDINGS INC | PURCHASEGRANT Stock grant | 303,000 | — | — | 303,000 | Jan 26, 2026 | Jan 28, 2026 ↗ | View → |
| ALXO ALX ONCOLOGY HOLDINGS INC | PURCHASEGRANT Stock grant | 198,750 | — | — | 198,750 | Oct 14, 2025 | Oct 16, 2025 ↗ | View → |
| ALXO ALX ONCOLOGY HOLDINGS INC | PURCHASE Chief Financial Officer | 75,000 | $0.78 | $58.4K | 75,000 | Aug 18, 2025 | Aug 20, 2025 ↗ | View → |
| ALXO ALX ONCOLOGY HOLDINGS INC | PURCHASEGRANT Stock grant | 125,000 | — | — | 125,000 | Apr 11, 2025 | Apr 15, 2025 ↗ | View → |
| ALXO ALX ONCOLOGY HOLDINGS INC | PURCHASEGRANT Stock grant | 600,000 | — | — | 600,000 | Jan 21, 2025 | Jan 23, 2025 ↗ | View → |